1[1]Bangma CH, Kranse R, Blijenberg BG et al.The free-to-total serum prostate specific antigen ratio for staging prostate carcinoma.J Uorl, 1997, 157(2): 544
2[2]Thiel R P, Oesterting JE, Wojno KJ et al.Multicenter compansion of the diagnostic performance of free prostate specific antigen.Urology, 1996, 48(6A, suppl): 45
3[3]Basso D, Fogar P, Navaglia F et al.Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when?Urology, 2000, 55(5): 710
4[4]Maeda H.Complexed prostate-specific antigen and its volume indexes in the detection of prostate cancer.Urology, 1999, 54: 225
5[5]Maras BH, Leck JP, Carr IM et al.Identification of a novel microsatellit e marker tightly linked to the KAI-1 gene for predicting prostate cancer progression.Eur Urol, 2000, 37(2): 228
6[6]Heston WD.Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.Urology, 1997, 49(3A Suppl): 104
7[7]Kawakami M, Nakayama J.Enhanced expression of prostate-specific membrane antigen in prostate cancer as revealed by in situ hybridization.Cancer Res, 1997, 57(12): 2321
8[8]Jioa B, Boyton A, Kenny G et al.Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity.Prostate, 1996, 58(1): 65
